Abstract: An article of footwear with a heel region including a posterior end of the article of footwear, a mid-foot region, and a forefoot region including an anterior end of the article of footwear; a lateral side, and a medial side opposite the lateral side; an upper; and a sole structure coupled to the upper. The sole structure has a midsole with a first cushioning element extending from the posterior end to the anterior end; a second cushioning element extending from the mid-foot region to the posterior end, the second cushioning element being formed of a different material than the first cushioning element; and a shell with a plurality of circumferentially-spaced apart protrusions, wherein each of the plurality of protrusions is directly coupled to the second cushioning element.

Abstract: The present invention relates to collagen hydrolysate for use as an active substance in order to delay the ageing of cells in the bodies of humans or animals.

Abstract: A sole structure for an article of footwear includes a bladder and at least one insert. The bladder includes an upper surface having a first portion defining a chamber and a second portion defining at least one recess adjacent to the chamber. The at least one insert is disposed within the at least one recess and has a top surface that is substantially flush with the first portion of the upper surface of the bladder. The first portion of the upper surface is exposed to the at least one insert.

Abstract: The present invention relates to a method for producing collagen peptide preparations comprising recombinant collagen peptides, to collagen peptide preparations produced by means of said methods, to products containing the collagen peptide preparations and to uses of the aforementioned preparations and products.

Abstract: The following invention relates to collagen hydrolysate for use as an active substance in the treatment and/or prophylaxis of periodontitis or gingivitis.

Abstract: The present invention relates to the use of collagen hydrolysate for improving endurance performance by increasing mitochondrial activity. Further, the invention relates to the use of collagen hydrolysate for stimulating lipid catabolism, and in particular for reducing body weight, by increasing mitochondrial activity.

Abstract: The present invention relates to a synthetically or recombinantly produced collagen peptide for use in a method for the therapeutic treatment of the human or animal body having a molecular weight in a range from 0.18 to 10.0 kDa, in particular 0.18 to 5.0 kDa, in particular 1.1 to 5.0 kDa, products which comprise a collagen peptide according to the invention, and a method for producing a collagen peptide according to the invention.

Abstract: The present invention relates to the use of collagen hydrolysate for improving endurance performance by increasing mitochondrial activity. Further, the invention relates to the use of collagen hydrolysate for stimulating lipid catabolism, and in particular for reducing body weight, by increasing mitochondrial activity.

Abstract: The present invention relates to collagen hydrolysate for use as an active substance in the treatment of inflammatory skin disorders and intestinal disorders and/or skin disorders and intestinal disorders accompanied by inflammation.

Abstract: The present invention relates to a method for producing collagen peptide preparations comprising recombinant collagen peptides, to collagen peptide preparations produced by means of said methods, to products containing the collagen peptide preparations and to uses of the aforementioned preparations and products.

Abstract: The invention provides an improved antioxidant for food, animal feed, cosmetics and pharmaceuticals, as well as compositions that contain this antioxidant as preferably the only additive having an anitoxidative effect.

Abstract: Presented are wear-resistant polymeric shields for reinforcing segments of footwear, methods for making/using such shields, and shoes with a high-strength, abrasion-resistant thermoplastic toe shield covering the shoe's front face. An athletic shoe includes an upper with an outer shell that receives a user's foot. A forefoot region of the upper's outer shell includes a toe box, while the forefoot and midfoot regions include a vamp. A sole structure is attached to the upper to support the user's foot. The sole structure includes a ground-engaging outsole and an outer-perimeter sidewall. A toe shield is bonded to and projects from outward-facing portions of the upper and sole structure. The toe shield is a single-piece structure fabricated from an abrasion-resistant, flexible thermoplastic copolymer. The toe shield may extend across forward portions of the vamp and toe box, a forward portion of the sole's sidewall, and a forward edge of the outsole's ground-facing surface.

Abstract: The present invention relates to the use of collagen hydrolysate for improving endurance performance by increasing mitochondrial activity. Further, the invention relates to the use of collagen hydrolysate for stimulating lipid catabolism, and in particular for reducing body weight, by increasing mitochondrial activity.

Abstract: The present invention relates to a collagen hydrolysate which is produced by enzymatic hydrolysis of type-B bone gelatin, wherein the collagen hydrolysate is formed from peptides of which at least 50% by weight, in particular at least 70% by weight have a molecular weight of 1,500 Da to 3,500 Da, and which have a mean molecular weight in the range from 4,000 Da to 8,000 Da, in particular in the range from 4,500 Da to 6,000 Da. The invention also relates to the use of this collagen hydrolysate as an active ingredient to maintain and/or improve the health of the bones, in particular to prevent and/or treat osteoporosis. The invention further relates to a nutritional supplement which comprises the collagen hydrolysate.

Abstract: The present invention relates to collagen hydrolysate as an active substance for treating sarcopenia, as an active substance against the degenerative loss of muscle mass and for improving muscle power, as an active substance for reducing the age-related loss of muscle mass, and as an active substance for stimulating the conversion of body fat mass to muscle mass. The invention further relates to a method for treating sarcopenia, comprising the repeated oral administration of collagen hydrolysate to a patient.

Abstract: Processes for the continuous production of fermented, trehalulose-containing beverages, in particular ready-to-drink beverages or beverage concentrates.

Abstract: The present invention relates to a trehalulose-containing composition, its preparation and use.

Abstract: A trehalulose-containing composition, its preparation and use.

Abstract: Articles of footwear having an upper that includes a tensile support structure are described. The tensile support structure is formed by a plurality of strands that are arranged in a chain-linked configuration. The chain-linked arrangement of the strands assists with distributing tensile forces over portions of the upper of the article of footwear and helps to conforms the upper to a foot of a wearer upon the application of tension.

Abstract: The present invention relates to dry aroma formulations containing a carrier-supported extract, in particular an extract carrier-supported on trehalose and/or isomaltulose as carrier, as well as methods for their production and uses thereof.